Global Hemostasis Diagnostic Devices and Equipment Market Report 2022: Analyzers, Coagulation Instrument, Hemostasis Instruments, Reagents and Kits – Analysis & Forecasts 2016-2021, 2021-2026F, 2031F – ResearchAndMarkets.com

Global Hemostasis Diagnostic Devices and Equipment Market Report 2022: Analyzers, Coagulation Instrument, Hemostasis Instruments, Reagents and Kits – Analysis & Forecasts 2016-2021, 2021-2026F, 2031F – ResearchAndMarkets.com




Global Hemostasis Diagnostic Devices and Equipment Market Report 2022: Analyzers, Coagulation Instrument, Hemostasis Instruments, Reagents and Kits – Analysis & Forecasts 2016-2021, 2021-2026F, 2031F – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Hemostasis Diagnostic Devices And Equipment Market Report 2022” report has been added to ResearchAndMarkets.com’s offering.

The global hemostasis diagnostic devices and equipment market is expected to grow from $4.1 billion in 2021 to $4.81 billion in 2022 at a compound annual growth rate (CAGR) of 17.4%. The market is expected to grow to $8.57 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%.

Major players in the hemostasis diagnostic devices and equipment market are C.R. Bard, Baxter International Inc, Pfizer Inc, Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc, Becton, Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, and F. Hoffmann-La Roche Ltd.

The hemostasis diagnostic devices and equipment market consists of sales of hemostasis diagnostic devices. Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation, and lastly vasoconstriction.

Three types of devices help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speed the clotting process. With the help of hemostasis diagnostic devices, we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.

The main products of hemostasis diagnostic devices and equipment are analyzers, coagulation instruments, other hemostasis instruments, and reagents and kits. A hemostasis diagnostic analyzer is a tool utilized to predict the cause of bleeding during surgery by identifying any hemostatic defects. The hemostasis diagnostic devices and equipment are automated, semi-automated, and manual that is used by hospitals, clinics, independent diagnostic, laboratories, and others.

North America was the largest region in the hemostasis diagnostic devices and equipment market in 2021. Asia Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The increased likelihood of older people being diagnosed with a disease is driving the number of surgeries such as cardiovascular diseases (CVD), using hemostasis devices. Due to the higher incidence of diseases with advancing age, there is an increase in the number of surgeries in elderly patients nowadays. These hemostasis devices are very efficient in speeding up the natural process of clotting in the blood and can monitor anticoagulation and transfusion therapy guidance in any surgery.

According to the American Heart Association report, Americans older than 80 have a high risk of devolving a cardiovascular disease (CVD), around 83% of men and 87.1% of females will be suffering from any form of CVD, therefore, to improve the comfort of the patient and the success rate of surgeries as a result hemostasis device has been implemented widely.

The use of hemostasis devices in hospitals or clinics requires a very lengthy approval procedure which is restraining the market. Before hemostasis devices can enter the market for commercial use they have to clear the regulations set by the Code of Federal Regulations (title 21).

The process of approval consists firstly identification of the device, secondly classification of the device and finally, the date of the pre-market approval (PMA) or the notice of completion of prescription drug plan (PDP) is required. It is a very long and time-consuming approval process that discourages new entrants from entering this market. For example, Cardiva Medical Inc. had to wait for a processing period of four months before they received approval to change the existing equipment with a newer and modern one.

The emergence of new and improved technology in the hemostasis diagnostic device and equipment market. To improve the quality and success rate of operations, new and improved technology such as the collagen vascular hemostasis devices have been implemented. Collagen is the main structural protein found in skin and other connective tissues. It is widely used in purified form for cosmetic surgical treatments and has now emerged in the hemostasis diagnostic devices market. A patient can face immobility right after a femoral surgery leading to increased discomfort, as a result, collagen-based closure devices have been implemented.

Key Topics Covered:

1. Executive Summary

2. Hemostasis Diagnostic Devices And Equipment Market Characteristics

3. Hemostasis Diagnostic Devices And Equipment Market Trends And Strategies

4. Impact Of COVID-19 On Hemostasis Diagnostic Devices And Equipment

5. Hemostasis Diagnostic Devices And Equipment Market Size And Growth

5.1. Global Hemostasis Diagnostic Devices And Equipment Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Hemostasis Diagnostic Devices And Equipment Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Hemostasis Diagnostic Devices And Equipment Market Segmentation

6.1. Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Analyzers
  • Coagulation Instrument
  • Other Hemostasis Instruments
  • Reagents and Kits

6.2. Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Hospitals
  • Clinics
  • Independent Diagnostic
  • Laboratories
  • Other End Users

6.3. Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Device Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Automated
  • Semi-Automated
  • Manual

7. Hemostasis Diagnostic Devices And Equipment Market Regional And Country Analysis

7.1. Global Hemostasis Diagnostic Devices And Equipment Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Hemostasis Diagnostic Devices And Equipment Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Companies Mentioned

  • C.R. Bard
  • Baxter International Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton
  • Dickinson and Company
  • Chrono-Log Corporation
  • CSL Behring LLC.
  • F. Hoffmann-La Roche Ltd.
  • Grifols
  • S.A.
  • HemCon Medical Technologies Inc.
  • Integra Life Sciences Corporation
  • Medtronic plc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc.
  • Ethicon
  • Boston Scientific
  • Olympus
  • Medtronic
  • Cook Medical
  • Halyard
  • Medline
  • Pentax
  • ConMed
  • Fujinon
  • Moog

For more information about this report visit https://www.researchandmarkets.com/r/8vph0v

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900